Remove 2011 Remove Competition Remove Course Remove Sales
article thumbnail

The Changing Venture Landscape

Both Sides of the Table

We have global opportunities from these trends but of course also big challenges. Of course we can’t. In 2001 companies IPO’d very quickly if they were working, by 2011 IPOs had slowed down to the point that in 2013 Aileen Lee of Cowboy Ventures astutely called billion-dollar outcomes “unicorns.” Hot, Flat & Crowded.”

article thumbnail

Interview with Fariborz Maseeh, Maseeh Entrepreneurship Prize Competition

socalTECH

Last week, the University of Southern California 's Viterbi School of Engineering announced that it had established a new, business plan competition, the Maseeh Entrepreneurship Prize Competition ([link] specifically aimed at students in the engineering school. Why a business plan competition, and why in engineering school?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Should Startups Focus on Profitability or Not?

Both Sides of the Table

The most obvious way to explain this is with sales people. If you hire 6 sales reps in January at $120,000 / year salary then you’ve taken on an extra $60,000 per month in costs yet these sales people might not close new business for 4-6 months. “COGS” represents the amount that each sale costs you.

Startup 418
article thumbnail

Why Startups Should Raise Money at the Top End of Normal

Both Sides of the Table

Then you can do a little bit of research and find out that very few companies ever achieve this valuation in a trade sale so you’re clearly gunning for an IPO. Well, obviously if you knew that in advance it would be big of course that would be true. And of course there are always outliers.

Startup 336
article thumbnail

8 Questions to Help Decide if You Should be Raising Money Now

Both Sides of the Table

A year ago I blogged about one of my most common mantras that applies to sales, biz dev & fund raising alike: “ Time is the Enemy of all Deals.&#. Only … ONLY … if there’s a sense of competition on the deal. Respectfully, of course. The market is over-valued in 2011 relative to norms.

Help 303
article thumbnail

Interview with Wes Nichols, MarketShare

socalTECH

We have a very sophisticated, analytics and software platform that over half the Fortune 50 are now using, to help guide how they invest in marketing and sales activities and investments. Jovian's platform allows us to process and analyze campaigns in-flight, and also provide in-flight course corrections for marketers.

article thumbnail

After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?

Xconomy

Five years ago, in November 2011, a company from Princeton, NJ, called Pharmasset shared news that would have an impact on millions of people around the world with hepatitis C. Sales of both drugs, ivacaftor (Kalydeco) and the combo pill ivacaftor-lumacaftor (Orkambi), reached almost $1 billion in 2015 and are growing.

Startup 40